Liberia women walk, after praying for help with the Ebola virus, in the city of Monrovia, Liberia. (AP Photo/Abbas Dulleh)
Your feedback is important to us!
We invite all our readers to share with us their views and comments about this article.
Disclaimer: Comments submitted by third parties on this site are the sole responsibility of the individual(s) whose content is submitted. The Daily Star accepts no responsibility for the content of comment(s), including, without limitation, any error, omission or inaccuracy therein. Please note that your email address will NOT appear on the site.
Alert: If you are facing problems with posting comments, please note that you must verify your email with Disqus prior to posting a comment. follow this link to make sure your account meets the requirements. (http://bit.ly/vDisqus)
MONROVIA, Liberia: Liberian officials faced a difficult choice Thursday: deciding which handful of Ebola patients will receive an experimental drug that could prove life-saving, ineffective or even harmful.ZMapp, the untested Ebola drug, arrived in the West African country late Wednesday. Assistant Health Minister Tolbert Nyenswah said three or four people would begin getting it Thursday, although another health official said there was only enough for three people.The government had previously said two doctors would receive the treatment, but it was unclear who else would.Massaquoi said there was only enough of the drug to treat three people.Health Minister Onyebuchi Chukwu said the latest patient is a doctor who helped treat the country's first Ebola case, Liberian-American Patrick Sawyer who flew in last month and died July 25 .
FOLLOW THIS ARTICLE